The astrocyte in multiple sclerosis revisited

GLIA

Volumn 61, Issue 4, 2013, Pages 453-465

  Brosnan, Celia F ^a   Raine, Cedric S ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Astrocytes; Blood brain barrier; Glia limitans; Multiple sclerosis

Indexed keywords

ARTICLE; ASTROCYTE; ASTROCYTOSIS; BASEMENT MEMBRANE; BLOOD BRAIN BARRIER; ENDOTHELIUM CELL; GLIA; HUMAN; HUMORAL IMMUNITY; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; SENSITIZATION; TISSUE INJURY;

ANIMALS; ASTROCYTES; BLOOD-BRAIN BARRIER; BRAIN; DEMYELINATING DISEASES; HUMANS; MULTIPLE SCLEROSIS; NEUROMYELITIS OPTICA; SPINAL CORD;

EID: 84873709602     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.22443     Document Type: Article

References (113)

1. Adams RD, Foley JM.1953.The neurological disorder associated with liver disease.Res Publ Assoc Res Nerv Ment Dis 32:198-237.
2. Agrawal S, Anderson P, Durbeej M, van Rooijen N, Ivars F, Opdenakker G, Sorokin LM.2006.Dystroglycan is selectively cleaved at the parenchymal basement membrane at sites of leukocyte extravasation in experimental autoimmune encephalomyelitis.J Exp Med 203:1007-1019.
3. Alvarez JI, Dodelet-Devillers A, Kebir H, Ifergan I, Fabre PJ, Terouz S, Sabbagh M, Wosik K, Bourbonnière L, Bernard M, van Horssen J, de Vries HE, Charron F, Prat A.2011.The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence.Science 334:1727-1731.
4. Amiry-Moghaddam M, Otsuka T, Hurn PD, Traystman RJ, Haug FM, Froehner SC, Adams ME, Neely JD, Agre P, Ottersen OP, Bhardwaj A.2003a.An alpha-syntrophin-dependent pool of AQP4 in astroglial end-feet confers bidirectional water flow between blood and brain.Proc Natl Acad Sci USA 100:2106-2111.
5. Amiry-Moghaddam M, Ottersen OP.2003b.The molecular basis of water transport in the brain.Nat Rev Neurosci 12:991-1001.
6. Argaw AT, Asp L, Zhang J, Navrazhina K, Pham T, Mariani JN, Mahase S, Dutta DJ, Seto J, Kramer EG, Ferrara N, Sofroniew MV, John GR.2012.Astrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS inflammatory disease.J Clin Invest 122:2454-2468.
7. Argaw AT, Gurfein BT, Zhang Y, Zameer A, John GR.2009.VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown.Proc Natl Acad Sci USA 106:1977-1982.
8. Argaw AT, Zhang Y, Snyder BJ, Zhao ML, Kopp N, Lee SC, Raine CS, Brosnan CF, John GR.2006.IL-1beta regulates blood-brain barrier permeability via reactivation of the hypoxia-angiogenesis program.J Immunol 177:5574-5584.
9. Azoulay D, Mausner-Fainberg K, Urshansky N, Fahoum F, Karni A.2009.Interferon-beta therapy up-regulates BDNF secretion from PBMCs of MS patients through a CD40-dependent mechanism.J Neuroimmunol 211:114-119.
10. Bachoo RM, Kim RS, Ligon KL, Maher EA, Brennan C, Billings N, Chan S, Li C, Rowitch DH, Wong WH, DePinho RA.2004.Molecular diversity of astrocytes with implications for neurological disorders.Proc Natl Acad Sci USA 101:8384-8389.
11. Bannerman P, Hahn A, Soulika A, Gallo V, Pleasure D.2007.Astrogliosis in EAE spinal cord: Derivation from radial glia, and relationships to oligodendroglia.Glia 55:57-64.
12. Bradbury EJ, Moon LD, Popat RJ, King VR, Bennett GS, Patel PN, Fawcett JW, McMahon SB.2002.Chondroitinase ABC promotes functional recovery after spinal cord injury.Nature 416:636-640.
13. Bradl M, Misu T, Takahashi T, Watanabe M, Mader S, Reindl M, Adzemovic M, Bauer J, Berger T, Fujihara K, Itoyama Y, Lassmann H.2009.Neuromyelitis optica: Pathogenicity of patient immunoglobulin in vivo.Ann Neurol 66:630-643.
14. Brambilla R, Persaud T, Hu X, Karmally S, Shestopalov VI, Dvoriantchikova G, Ivanov D, Nathanson L, Barnum SR, Bethea JR.2009.Transgenic inhibition of astroglial NF-kappa B improves functional outcome in experimental autoimmune encephalomyelitis by suppressing chronic central nervous system inflammation.J Immunol 182:2628-2640.
15. Brosnan CF, Battistini L, Raine CS, Dickson DW, Casadevall A, Lee SC.1994.Reactive nitrogen intermediates in human neuropathology: An overview.Dev Neurosci 16:152-161.
16. Brosnan CF, Cannella B, Battistini L, Raine CS.1995.Cytokine localization in multiple sclerosis lesions: Correlation with adhesion molecule expression and reactive nitrogen species.Neurology 45 (6 Suppl 6):S16-S21.
17. Bush TG, Puvanachandra N, Horner CH, Polito A, Ostenfeld T, Svendsen CN, Mucke L, Johnson MH, Sofroniew MV.1999.Leukocyte infiltration, neuronal degeneration, and neurite outgrowth after ablation of scar-forming, reactive astrocytes in adult transgenic mice.Neuron 23:297-308.
18. Campbell IL, Abraham CR, Masliah E, Kemper P, Inglis JD, Oldstone MB, Mucke L.1993.Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6.Proc Natl Acad Sci USA 9021:10061-10065.
19. Campbell IL, Hofer MJ, Pagenstecher A.2010.Transgenic models for cytokine-induced neurological disease.Biochim Biophys Acta 1802:903-917.
20. Cannella B, Raine CS.1995.The adhesion molecule and cytokine profile of multiple sclerosis lesions.Ann Neurol 37:424-435.
21. Charcot JM.1868.Histologie de la sclerose en plaque.Gaz Hop 41:554-558.
22. Colombo E, Cordiglieri C, Melli G, Newcombe J, Krumbholz M, Parada LF, Medico E, Hohlfeld R, Meinl E, Farina C.2012.Stimulation of the neurotrophin receptor TrkB on astrocytes drives nitric oxide production and neurodegeneration.J Exp Med 209:521-535.
23. Crocker SJ, Whitmire JK, Frausto RF, Chertboonmuang P, Soloway PD, Whitton JL, Campbell IL.2006.Persistent macrophage/microglial activation and myelin disruption after experimental autoimmune encephalomyelitis in tissue inhibitor of metalloproteinase-1-deficient mice.Am J Pathol 169:2104-2116.
24. Cross AH, Manning PT, Stern MK, Misko TP.1997.Evidence for the production of peroxynitrite in inflammatory CNS demyelination.J Neuroimmunol 80:121-130.
25. D'Amelio FE, Smith ME, Eng LF.1990.Sequence of tissue responses in the early stages of experimental allergic encephalomyelitis (EAE): Immunohistochemical, light microscopic, and ultrastructural observations in the spinal cord.Glia 3:229-240.
26. Ding JH, Sha LL, Chang J, Zhou XQ, Fan Y, Hu G.2007.Alterations of striatal neurotransmitter release in aquaporin-4 deficient mice: An in vivo microdialysis study.Neurosci Lett 422:175-180.
27. Dubois B, Masure S, Hurtenbach U, Paemen L, Heremans H, van den Oord J, Sciot R, Meinhardt T, Hammerling G, Opdenakker G, Arnold B.1999.Resistance of young gelatinase B-deficient mice to experimental autoimmune encephalomyelitis and necrotizing tail lesions.J Clin Invest 104:1507-1515.
28. Fancy SP, Kotter MR, Harrington EP, Huang JK, Zhao C, Rowitch DH, Franklin RJ.2010.Overcoming remyelination failure in multiple sclerosis and other myelin disorders.Exp Neurol 225:18-23.
29. Faulkner JR, Herrmann JE, Woo MJ, Tansey KE, Doan NB, Sofroniew MV.2004.Reactive astrocytes protect tissue and preserve function after spinal cord injury.J Neurosci 24:2143-2155.
30. Fawcett JW.2006.Overcoming inhibition in the damaged spinal cord.J Neurotrauma 23:371-383.
31. Gijbels K, Galardy RE, Steinman L.1994.Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases.J Clin Invest 94:2177-2182.
32. Graesser D, Mahooti S, Madri JA.2000.Distinct roles for matrix metalloproteinase-2 and alpha4 integrin in autoimmune T cell extravasation and residency in brain parenchyma during experimental autoimmune encephalomyelitis.J Neuroimmunol 109:121-131.
33. Herrmann JE, Imura T, Song B, Qi J, Ao Y, Nguyen TK, Korsak RA, Takeda K, Akira S, Sofroniew MV.2008.STAT3 is a critical regulator of astrogliosis and scar formation after spinal cord injury.J Neurosci 28:7231-7243.
34. Hinson SR, McKeon A, Lennon VA.2010.Neurological autoimmunity targeting aquaporin-4.Neuroscience 168:1009-1018.
35. Hinson SR, Pittock SJ, Lucchinetti CF, Roemer SF, Fryer JP, Kryzer TJ, Lennon VA.2007.Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica.Neurology 69:2221-2231.
36. Hinson SR, Roemer SF, Lucchinetti CF, Fryer JP, Kryzer TJ, Chamberlain JL, Howe CL, Pittock SJ, Lennon VA.2008.Aquaporin-4-binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2.J Exp Med 205:2473-2481.
37. Hinson SR, Romero MF, Popescu BF, Lucchinetti CF, Fryer JP, Wolburg H, Fallier-Becker P, Noell S, Lennon VA.2012.Molecular outcomes of neuromyelitis optica (NMO)-IgG binding to aquaporin-4 in astrocytes.Proc Natl Acad Sci USA 109:1245-1250.
38. Ishii M, Maeda N.2008.Oversulfated chondroitin sulfate plays critical roles in the neuronal migration in the cerebral cortex.J Biol Chem 283:32610-32620.
39. Jack C, Antel J, Brück W, Kuhlmann T.2007.Contrasting potential of nitric oxide and peroxynitrite to mediate oligodendrocyte injury in multiple sclerosis.Glia 55:926-934.
40. Jarius S, Wildemann B.2010.AQP4 antibodies in neuromyelitis optica: Diagnostic and pathogenetic relevance.Nat Rev Neurol 6:383-392.
41. Javeri S, Rodi M, Tary-Lehmann M, Lehmann PV, Addicks K, Kuerten S.2010.Involvement of brain-derived neurotrophic factor (BDNF) in MP4-induced autoimmune encephalomyelitis.Clin Immunol 137:181-189.
42. John GR, Shankar SL, Shafit-Zagardo B, Massimi A, Lee SC, Raine CS, Brosnan CF.2002.Multiple sclerosis: Re-expression of a developmental pathway that restricts oligodendrocyte maturation.Nat Med 8:1115-1121.
43. Kang Z, Altuntas CZ, Gulen MF, Liu C, Giltiay N, Qin H, Liu L, Qian W, Ransohoff RM, Bergmann C, Stohlman S, Tuohy VK, Li X.2010.Astrocyte-restricted ablation of interleukin-17-induced Act1-mediated signaling ameliorates autoimmune encephalomyelitis.Immunity 32:414-425.
44. Kinoshita M, Nakatsuji Y, Moriya M, Okuno T, Kumanogoh A, Nakano M, Takahashi T, Fujihara K, Tanaka K, Sakoda S.2009.Astrocytic necrosis is induced by anti-aquaporin-4 antibody-positive serum.Neuroreport 20:508-512.
45. Kriegstein A, Alvarez-Buylla A.2009.The glial nature of embryonic and adult neural stem cells.Ann Rev Neurosci 32:149-184.
46. Lassmann H, Zimprich F, Vass K, Hickey WF.1991.Microglial cells are a component of the perivascular glia limitans.J Neurosci Res 28:236-243.
47. Lee SC, Moore GR, Golenwsky G, Raine CS.1990.Multiple sclerosis: A role for astroglia in active demyelination suggested by class II MHC expression and ultrastructural study.J Neuropathol Exp Neurol 49:122-136.
48. Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, Nakashima I, Weinshenker BG.2004.A serum autoantibody marker of neuromyelitis optica: Distinction from multiple sclerosis.Lancet 364:2106-2112.
49. Liedtke W, Cannella B, Mazzaccaro RJ, Clements JM, Miller KM, Wucherpfennig KW, Gearing AJ, Raine CS.1998a.Effective treatment of models of multiple sclerosis by matrix metalloproteinase inhibitors.Ann Neurol 44:35-46.
50. Liedtke W, Edelmann W, Bieri PL, Chiu FC, Cowan NJ, Kucherlapati R, Raine CS.1996.GFAP is necessary for the integrity of CNS white matter architecture and long-term maintenance of myelination.Neuron 17:607-615.
51. Liedtke W, Edelmann W, Chiu FC, Kucherlapati R, Raine CS.1998b.Experimental autoimmune encephalomyelitis in mice lacking glial fibrillary acidic protein is characterized by a more severe clinical course and an infiltrative central nervous system lesion.Am J Pathol 152:251-259.
52. Lindberg RL, De Groot CJ, Montagne L, Freitag P, van der Valk P, Kappos L, Leppert D.2001.The expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in lesions and normal appearing white matter of multiple sclerosis.Brain 124:1743-1753.
53. Linker RA, Lee DH, Demir S, Wiese S, Kruse N, Siglienti I, Gerhardt E, Neumann H, Sendtner M, Lühder F, Gold R.2010.Functional role of brain-derived neurotrophic factor in neuroprotective autoimmunity: Therapeutic implications in a model of multiple sclerosis.Brain 133:2248-2263.
54. Liu JS, Zhao ML, Brosnan CF, Lee SC.2001.Expression of inducible nitric oxide synthase and nitrotyrosine in multiple sclerosis lesions.Am J Pathol 158:2057-2066.
55. Lucchinetti CF, Mandler RN, McGavern D, Bruck W, Gleich G, Ransohoff RM, Trebst C, Weinshenker B, Wingerchuk D, Parisi JE, Lassmann H.2002.A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica.Brain 125:1450-1461.
56. Ludwin SK, Raine CS.2008.The neuropathology of multiple sclerosis. In: Raine, CS, McFarland, HF, Hohlfeld R, editors. Multiple sclerosis: A comprehensive text. Edinburgh:Elsevier/Sanders Publishers. pp 151-157.
57. Ludwin SK.1994.Central nervous system remyelination: Studies in chronically damaged tissue (Review).Ann Neurol 36(Suppl):S143-S145.
58. Luo J, Ho P, Steinman L, Wyss-Coray T.2008.Bioluminescence in vivo imaging of autoimmune encephalomyelitis predicts disease.J Neuroinflammation 5:6.
59. Lutz SE, Zhao Y, Gulinello M, Lee SC, Raine CS, Brosnan CF.2009.Deletion of astrocyte connexins 43 and 30 leads to a dysmyelinating phenotype and hippocampal CA1 vacuolation.J Neurosci 29:7743-7752.
60. Manley GT, Fujimura M, Ma T, Noshita N, Filiz F, Bollen AW, Chan P, Verkman AS.2000.Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke.Nat Med 6:159-163.
61. Mansour H, Asher R, Dahl D, Labkovsky B, Perides G, Bignami A.1990.Permissive and non-permissive reactive astrocytes: Immunofluorescence study with antibodies to the glial hyaluronate-binding protein.J Neurosci Res 25:300-311.
62. Mathiisen TM, Lehre KP, Danbolt NC, Ottersen OP.2010.The perivascular astroglial sheath provides a complete covering of the brain microvessels: An electron microscopic 3D reconstruction.Glia 58:1094-1103.
63. Matute C, Sanchez-Gomez MV, Martinez-Millan L, Miledi R.1997.Glutamate receptor-mediated toxicity in optic nerve oligodendrocytes.Proc Natl Acad Sci USA 94:8830-8835.
64. Matute C, Torre I, Perez-Cerda F, Perez-Samartin A, Alberdi E, Etxebarria E, Arranz AM, Ravid R, Rodriguez-Antiguedad A, Sanchez-Gomez M, Domercq M.2007.P2X(7) receptor blockade prevents ATP excitotoxicity in oligodendrocytes and ameliorates experimental autoimmune encephalomyelitis.J Neurosci 27:9525-9533.
65. Misu T, Fujihara K, Kakita A, Konno H, Nakamura M, Watanabe S, Takahashi T, Nakashima I, Takahashi H, Itoyama Y.2007.Loss of aquaporin 4 in lesions of neuromyelitis optica: Distinction from multiple sclerosis.Brain 130:1224-1234.
66. Misu T, Takano R, Fujihara K, Takahashi T, Sato S, Itoyama Y.2009.Marked increase in cerebrospinal fluid glial fibrillar acidic protein in neuromyelitis optica: An astrocytic damage marker.J Neurol Neurosurg Psychiatry 80:575-577.
67. Müller E, editor.1904.Pathologische anatomie und pathogenese. In: Die multiple Sklerose des Gehirns und Rückenmarks.Jena:Gustav Fischer. pp 300-344.
68. Myer DJ, Gurkoff GG, Lee SM, Hovda DA, Sofroniew MV.2006.Essential protective roles of reactive astrocytes in traumatic brain injury.Brain 129:2761-2772.
69. Nair A, Frederick TJ, Miller SD.2008.Astrocytes in multiple sclerosis: A product of their environment.Cell Mol Life Sci 65:2702-2720.
70. Nait-Oumesmar B, Picard-Riera N, Kerninon C, Baron-Van Evercooren A.2008.The role of SVZ-derived neural precursors in demyelinating diseases: From animal models to multiple sclerosis.J Neurol Sci 265:26-31.
71. Nakahara J, Kanekura K, Nawa M, Aiso S, Suzuki N.2009.Abnormal expression of TIP30 and arrested nucleocytoplasmic transport within oligodendrocyte precursor cells in multiple sclerosis.J Clin Invest 119:169-181.
72. Neely JD, Amiry-Moghaddam M, Ottersen OP, Froehner SC, Agre P, Adams ME.2001.Syntrophin-dependent expression and localization of Aquaporin-4 water channel protein.Proc Natl Acad Sci USA 98:14108-14113.
73. Noell S, Fallier-Becker P, Beyer C, Kroger S, Mack AF, Wolburg H.2007.Effects of agrin on the expression and distribution of the water channel protein aquaporin-4 and volume regulation in cultured astrocytes.Eur J Neurosci 26:2109-2118.
74. Oohira A, Matsui F, Tokita Y, Yamauchi S, Aono S.2000.Molecular interactions of neural chondroitin sulfate proteoglycans in the brain development.Arch Biochem Biophysics 374:24-23.
75. Orthmann-Murphy JL, Abrams CK, Scherer SS.2008.Gap junctions couple astrocytes and oligodendrocytes (Review).J Mol Neurosci 35:101-116.
76. Owens T, Bechmann I, Engelhardt B.2008.Perivascular spaces and the two steps to neuroinflammation.J Neuropathol Expt Neurol 67:1113-1121.
77. Pagenstecher A, Stalder AK, Kincaid CL, Shapiro SD, Campbell IL.1998.Differential expression of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase genes in the mouse central nervous system in normal and inflammatory states.Am J Pathol 152:729-741.
78. Parratt JD, Prineas JW.2010.Neuromyelitis optica: A demyelinating disease characterized by acute destruction and regeneration of perivascular astrocytes.Mult Scler 16:1156-1172.
79. Pitt D, Werner P, Raine CS.2000.Glutamate excitotoxicity in a model of multiple sclerosis.Nat Med 6:67-70.
80. Prineas JW, Barnard RO, Revesz T, Kwon EE, Sharer L, Cho ES. 1993.Multiple sclerosis: Pathology of recurrent lesions.Brain 116:681-693.
81. Raine CS, Scheinberg L, Waltz JM.1981.Multiple sclerosis. Oligodendrocyte survival and proliferation in an active established lesion.Lab Invest 45:534-546.
82. Raine CS, Wu E.1993.Multiple sclerosis: Remyelination in acute lesions.J Neuropathol Exp Neurol 52:199-204.
83. Raine CS.1978.Membrane specialisations between demyelinated axons and astroglia in chronic EAE lesions and multiple sclerosis plaques.Nature 275:326-327.
84. Raine CS.1984.Biology of disease. The analysis of autoimmune demyelination: Its impact upon multiple sclerosis.Lab Invest 50:608-635.
85. Raine CS.1997.Oligodendrocytes and central nervous system myelin. In: Davis RL, Robertson DM, editors. Textbook of neuropathology, 3rd ed.Baltimore: Williams and Wilkins. pp 137-164.
86. Roemer SF, Parisi JE, Lennon VA, Benarroch EE, Lassmann H, Bruck W, Mandler RN, Weinshenker BG, Pittock SJ, Wingerchuk DM, Lucchinetti CF. 2007.Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis.Brain 130:1194-1205.
87. Roitbak T, Sykova E.1999.Diffusion barriers evoked in the rat cortex by reactive astrogliosis.Glia 28:40-48.
88. Rolls A, Shechter R, Schwartz M.2009.The bright side of the glial scar in CNS repair.Nat Rev Neurosci 10:235-241.
89. Sabater L, Giralt A, Boronat A, Hankiewicz K, Blanco Y, Llufriu S, Alberch J, Graus F, Saiz A.2009.Cytotoxic effect of neuromyelitis optica antibody (NMO-IgG) to astrocytes: An in vitro study.J Neuroimmunol 215:31-35.
90. Sarafian TA, Montes C, Imura T, Qi J, Coppola G, Geschwind DH, Sofroniew MV.2010.Disruption of astrocyte STAT3 signaling decreases mitochondrial function and increases oxidative stress in vitro.PLoS One 5:e9532.
91. Silver J, Miller JH.2004.Regeneration beyond the glial scar.Nat Rev Neurosci 5:146-156.
92. Sirko S, von Holst A, Weber A, Wizenmann A, Theocharidis U, Gotz M, Faissner A.2010.Chondroitin sulfates are required for fibroblast growth factor-2-dependent proliferation and maintenance in neural stem cells and for epidermal growth factor-dependent migration of their progeny.Stem Cells 28:775-787.
93. Sirko S, von Holst A, Wizenmann A, Gotz M, Faissner A.2007.Chondroitin sulfate glycosaminoglycans control proliferation, radial glia cell differentiation and neurogenesis in neural stem/progenitor cells.Development 134:2727-2738.
94. Sobel RA, Ahmed AS.2001.White matter extracellular matrix chondroitin sulfate/dermatan sulfate proteoglycans in multiple sclerosis.J Neuropathol Exp Neurol 60:1198-1207.
95. Sofroniew MV, Vinters HV.2010.Astrocytes: Biology and pathology.Acta Neuropathol 119:7-35.
96. Sofroniew MV.2009.Molecular dissection of reactive astrogliosis and glial scar formation.Trends Neurosci 32:638-647.
97. Stadelmann C, Kerschensteiner M, Misgeld T, Brück W, Hohlfeld R, Lassmann H.2002.BDNF and gp145trkB in multiple sclerosis brain lesions: Neuroprotective interactions between immune and neuronal cells?Brain 125:75-85.
98. Takeda K, Kaisho T, Yoshida N, Takeda J, Kishimoto T, Akira S.1998.Stat3 activation is responsible for IL-6-dependent T cell proliferation through preventing apoptosis: Generation and characterization of T cell-specific Stat3-deficient mice.J Immunol 161:4652-4660.
99. Tsai HH, Li H, Fuentealba LC, Molofsky AV, Taveira-Marques R, Zhuang H, Tenney A, Murnen AT, Fancy SP, Merkle F, Kessaris N, Alvarez-Buylla A, Richardson WD, Rowitch DH.2012.Regional astrocyte allocation regulates CNS synaptogenesis and repair.Science 2012 337:358-362.
100. Verkman AS, Binder DK, Bloch O, Auguste K, Papadopoulos MC.2006.Three distinct roles of aquaporin-4 in brain function revealed by knockout mice.Biochim Biophys Acta 1758:1085-1093.
101. Voskuhl RR, Peterson RS, Song B, Ao Y, Morales LB, Tiwari-Woodruff S, Sofroniew MV.2009.Reactive astrocytes form scar-like perivascular barriers to leukocytes during adaptive immune inflammation of the CNS.J Neurosci 29:11511-11522.
102. Wang D, Ayers MM, Catmull DV, Hazelwood LJ, Bernard CC, Orian JM.2005.Astrocyte-associated axonal damage in pre-onset stages of experimental autoimmune encephalomyelitis.Glia 51:235-240.
103. Waters P, Vincent A.2008.Detection of anti-aquaporin-4 antibodies in neuromyelitis optica: Current status of the assays (Review).Int MS J 15:99-105.
104. Werner P, Pitt D, Raine CS.2001.Multiple sclerosis: Altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage.Ann Neurol 50:169-180.
105. Williams A, Piaton G, Lubetzki C.2007.Astrocytes--Friends or foes in multiple sclerosis?Glia 55:1300-1312.
106. Williams KC, Ulvestad E, Hickey WF.1994.Immunology of multiple sclerosis (Review).Clin Neurosci 2:229-245.
107. Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG.2007a.The spectrum of neuromyelitis optica.Lancet Neurol 6:805-815.
108. Wingerchuk DM.2007b.Neuromyelitis optica: New findings on pathogenesis.Int Rev Neurobiol 79:665-688.
109. Wolburg-Buchholz K, Mack AF, Steiner E, Pfeiffer F, Engelhardt B, Wolburg H.2009.Loss of astrocyte polarity marks blood-brain barrier impairment during experimental autoimmune encephalomyelitis.Acta Neuropathol 118:219-233.
110. Wu E, Brosnan CF, Raine CS.1993.SP-40, 40 immunoreactivity in inflammatory CNS lesions displaying astrocyte/oligodendrocyte interactions.J Neuropathol Exp Neurol 52:129-134.
111. Wu E, Raine CS.1992.Multiple sclerosis. Interactions between oligodendrocytes and hypertrophic astrocytes and their occurrence in other, nondemyelinating conditions.Lab Invest 67:88-99.
112. Yong VW.2009.Prospects of repair in multiple sclerosis.J Neurol Sci 277(Suppl 1):S16-S18.
113. Zeng XN, Sun XL, Gao L, Fan Y, Ding JH, Hu G.2007.Aquaporin-4 deficiency down-regulates glutamate uptake and GLT-1 expression in astrocytes.Mol Cell Neurosci 34:34-39.